Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
– Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft […]
TSX News -
Canoe Financial proposes changes to Canoe Premium Income Fund
CALGARY, Alberta, March 28, 2024 (GLOBE NEWSWIRE) — Canoe Financial LP (“Canoe Financial”) announced today its intent to make changes […]
California Water Service Group Recognized by Newsweek as One of “America’s Most Trustworthy Companies”
SAN JOSE, Calif., March 28, 2024 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE: CWT) announced today that it […]
Armada Hoffler to Discuss First Quarter Earnings on May 9th
VIRGINIA BEACH, Va., March 28, 2024 (GLOBE NEWSWIRE) — Armada Hoffler (NYSE: AHH) will report its earnings for the quarter […]
Ryman Hospitality Properties, Inc. Announces Closing of $1.0 Billion of 6.500% Senior Notes Due 2032
NASHVILLE, Tenn., March 28, 2024 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) announced today that its […]
CEA Industries Inc. Reports Fourth Quarter and Full Year 2023 Results
Louisville, Colorado, March 28, 2024 (GLOBE NEWSWIRE) — CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), is […]
AGBA Announces Fourth Quarter 2023 Earnings, Amid Challenging Macro Environment.
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or “the Company”) the leading one-stop […]
Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) […]
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth-Quarter and Full-Year Fiscal 2023 Results; Posts 11% Annual Sales Growth; Announces 3% Increase in Quarterly Dividend
Full-year sales increased 11% to $1.57 billion Fiscal 2023 GAAP EPS of $3.82 impacted by noncash impairment charges of $5.32 […]
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
